The connection between music and the cardiovascular system has been studied for over a century, but the last two decades of research have clarified the mechanisms with a precision that gives clinicians genuine tools rather than intuitions.
The core phenomenon is cardiovascular entrainment: the synchronization of heart rate, respiratory rate, and blood pressure to rhythmic musical stimuli. This is not simply "music makes people feel calm, and calm people have lower heart rates." The mechanism is more direct than that, and the clinical implications are different.
The autonomic nervous system as the pathway
Heart rate is regulated by the autonomic nervous system — specifically the balance between sympathetic (fight-or-flight) and parasympathetic (rest-and-digest) tone. Music influences this balance through several converging pathways:
Respiratory entrainment. Slow music reduces respiratory rate. Slower breathing increases vagal tone (parasympathetic activity), which directly lowers heart rate. This is one mechanism behind the widely documented effect of slow music on heart rate — it's partly mediated through respiration.
Direct auditory-autonomic coupling. Research has also identified a more direct pathway: rhythmic auditory input activates the brainstem's reticular formation, which has direct projections to the autonomic regulatory nuclei. This pathway allows music to influence autonomic tone even in patients who are mechanically ventilated and cannot change their breathing pattern voluntarily.
Cortical emotion pathways. Music activates the limbic system. Positive emotional response activates parasympathetic tone; emotional arousal or tension activates sympathetic tone. This pathway is why music the patient finds pleasant produces different cardiovascular effects than acoustically matched music the patient finds neutral or unpleasant.
The evidence in cardiac populations
Multiple randomized controlled trials have studied music in cardiac settings:
Preoperative cardiac surgery: Studies have shown that music listening in the hour before cardiac surgery significantly reduces heart rate, systolic blood pressure, and self-reported anxiety compared to control conditions. The effect is reliable enough that several cardiac surgery programs have implemented music protocols as standard pre-procedural care.
ICU post-cardiac surgery: A 2018 meta-analysis of music in cardiac ICU settings found significant reductions in heart rate and blood pressure during music listening periods, with corresponding reductions in patient-reported pain and anxiety. Notably, the effect on pain was independent of the effect on heart rate — suggesting multiple parallel mechanisms.
Cardiac rehabilitation: RCTs of music-augmented cardiac rehabilitation exercise programs show improved adherence to training protocols and, in some studies, marginally greater cardiovascular fitness improvements compared to rehabilitation without music. The motivational effect of music during exercise contributes to more consistent exertion.
Heart failure management: Pilot studies suggest that regular music listening reduces sympathetic nervous system markers (plasma catecholamines) in patients with heart failure. This is an area of ongoing investigation.
The 60 BPM protocol
The most commonly recommended tempo for cardiac relaxation protocols is 60–70 BPM. The rationale is direct: resting heart rate in healthy adults is 60–100 BPM, with many patients in cardiac rehabilitation having resting rates above the normal range due to deconditioning, anxiety, or medication effects. Music at 60 BPM is slightly below resting rate for many of these patients — and cardiovascular entrainment pulls heart rate toward the musical tempo.
This is the physiological basis for the piece "Heartbeat" in Mowjera's therapy collection: the contrabass plays an unwavering quarter-note pulse at 60 BPM throughout the piece. The pulse is not decorative; it is the clinical mechanism. The violin melody gives the patient something to listen to and prevents the piece from feeling like a metronome, but the pulse is the active ingredient.
Heart rate variability: the more sophisticated target
Heart rate variability (HRV) — the millisecond-to-millisecond variation in intervals between heartbeats — is increasingly recognized as a more sensitive and clinically meaningful marker of cardiovascular health than average heart rate. Higher HRV reflects better autonomic flexibility and is associated with better cardiovascular outcomes, better stress resilience, and better mental health.
Music listening has been shown to increase HRV in healthy participants and in cardiac patients. The effect is strongest for music at approximately 0.1 Hz (6 cycles per minute, or one respiratory cycle every 10 seconds), which corresponds roughly to 60 BPM music that entrains breathing to 6 breaths per minute. This breathing rate maximizes a baroreflex-mediated HRV oscillation called the Mayer wave — a target of HRV biofeedback protocols.
This convergence between HRV biofeedback and music therapy is clinically significant: music can be used as a non-technical, accessible alternative to formal biofeedback equipment for patients who are working on HRV improvement as part of cardiac rehabilitation or stress management.
Practical implementation
For clinicians implementing music in cardiac settings:
- Target 60–70 BPM for relaxation and recovery protocols.
- Use music without lyrics — language processing maintains cortical arousal.
- Ensure patient preference is honored — the emotional pathway contributes meaningfully to the cardiovascular effect, and music the patient finds unpleasant or irritating will increase sympathetic tone regardless of tempo.
- Monitor heart rate during initial sessions — individual entrainment responses vary, and establishing baseline response characteristics helps with personalization.
- Consider pre-procedural protocols separately from rehabilitation protocols — the goals differ (acute anxiety reduction vs. sustained physiological training), and different musical approaches may be optimal.
The growing body of evidence supports music as a low-cost, high-access adjunct in cardiac care. It will not replace pharmacological management of arrhythmia, hypertension, or heart failure — but for adjunctive anxiety management, rehabilitation adherence, and HRV-targeted protocols, the evidence base is solid enough to support clinical implementation now.